{"id":16174,"date":"2019-05-10T02:00:28","date_gmt":"2019-05-10T00:00:28","guid":{"rendered":"https:\/\/www.somo.nl\/nl\/?p=16174"},"modified":"2023-07-10T18:01:13","modified_gmt":"2023-07-10T16:01:13","slug":"dure-medicijnen-ontwikkeld-met-belastinggeld","status":"publish","type":"post","link":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/","title":{"rendered":"Dure medicijnen ontwikkeld met belastinggeld"},"content":{"rendered":"\n<div  data-name=\"acf\/block-post-meta\" class=\"mt-6 alignwide alignwide--narrow\">\n\t<div class=\"flex flex-wrap items-center gap-4 lg:gap-7\">\n\n\t\t\t\t\t<div class=\"flex flex-wrap items-center gap-2\">\n\t\t\t\t\t\t\t\t\t<span class=\"sr-only\">Geplaatst in categorie:<\/span>\n\t\t\t\t\t<div data-component=\"badge\" class=\"flex\">\n\t\t<div class=\"relative px-2 py-1 text-sm antialiased font-bold lowercase font-heading text-base-50 bg-nightblue-700\">\n\t\tNieuws\n\t<\/div>\n<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t<div class=\"flex items-center gap-2\">\n\t\t\t<span class=\"sr-only\">Gepubliceerd op:<\/span>\n\t\t\t<span class=\"icon svg:w-[20px] svg:h-[20px]\" aria-hidden=\"true\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M6.75 0a.75.75 0 0 1 .75.75V3h9V.75a.75.75 0 0 1 1.5 0V3h3.75A2.25 2.25 0 0 1 24 5.25v16.5A2.25 2.25 0 0 1 21.75 24H2.25A2.25 2.25 0 0 1 0 21.75V5.25A2.25 2.25 0 0 1 2.25 3H6V.75A.75.75 0 0 1 6.75 0Zm9.75 4.5V6A.75.75 0 0 0 18 6V4.5h3.75a.75.75 0 0 1 .75.75V9h-21V5.25a.75.75 0 0 1 .75-.75H6V6a.75.75 0 0 0 1.5 0V4.5h9Zm6 6v11.25a.75.75 0 0 1-.75.75H2.25a.75.75 0 0 1-.75-.75V10.5h21Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n\t\t\t<time class=\"text-base\" datetime=\"2019-05-10\">10 mei 2019<\/time>\n\t\t<\/div>\n\n\t\t\n\t\t\t<\/div>\n<\/div>\n\n\n<h2><strong>Onderzoek toont grote publieke investeringen in medicijnontwikkeling<\/strong><\/h2>\n<p>Vandaag publiceren SOMO en Wemos het <a href=\"https:\/\/www.somo.nl\/nl\/overpriced\/\">rapport \u2018Overpriced\u2019<\/a> waaruit blijkt dat er zowel direct als indirect veel publiek geld in de ontwikkeling van nieuwe medicijnen wordt gestoken. Naast directe financiering van universiteiten, gaat publiek geld o.a. via nationale en regionale investeringsfondsen naar biotechbedrijven. Er worden echter geen voorwaarden gesteld aan deze giften, leningen en investeringen, waardoor de overheid kansen laat liggen om de medicijnprijzen te beteugelen. SOMO en Wemos pleiten daarom voor coherent overheidsbeleid, waarin publieke belangen, zoals de financi\u00eble houdbaarheid van ons zorgstelsel en toegang tot medicijnen, zwaarder meewegen wanneer publiek geld ge\u00efnvesteerd wordt.<\/p>\n<blockquote><p><a href=\"https:\/\/www.somo.nl\/nl\/overpriced\/\">Overpriced<\/a><\/p>\n<p>Esther de Haan (senior onderzoeker bij SOMO): \u201cHet argument van de farmaceutische bedrijven dat medicijnen zo duur zijn vanwege hoge kosten voor Research &amp; Development, is niet correct. Een deel van deze kosten en risico\u2019s wordt gedragen door publieke partijen zonder dat zij voorwaarden verbinden aan hun investeringen. Dit is een gemiste kans van de overheid om invloed op de hoge medicijnprijzen uit te oefenen.\u201d<\/p><\/blockquote>\n<p>In samenwerking met Wemos, onderzocht SOMO de directe en indirecte investeringen in medicijnonderzoek en -ontwikkeling, door middel van deskresearch, interviews met experts en casestudies.<\/p>\n<p>\n<div data-component=\"oembed\" class=\"max-w-5xl\" data-module=\"oembed\" data-source=\"consent_embed_youtube\" data-type=\"video\" data-cookiebot=\"1\" data-disable-notice=\"\">\n\t<div data-oembed=\"content\">\n\t\t<div data-oembed=\"placeholder\" class=\"flex flex-col items-center justify-center h-full text-center bg-beige\">\n\t\t\t<div class=\"p-8\">\n\t\t\t\t<p class=\"mb-7\" id=\"embed-cookie-6a23bee0890ee\">Deze inhoud is beschikbaar na het accepteren van de cookies.<\/p>\n\t\t\t\t\n\n\n\n\n\n\t\n\n<button\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer text-base font-bold py-3 border-2 border-red bg-red text-base-50 hocus:bg-red-700 hocus:border-red-700 px-6 font-body js-consent-button\"\n\t\t\thref=\"https&#x3A;&#x2F;&#x2F;www.youtube.com&#x2F;watch&#x3F;v&#x3D;BQUrBBSw46k\"\n\t\t\t\t\t\ttype=\"button\"\n\t\t\t\t\t\t\t\taria-describedby=\"embed-cookie-6a23bee0890ee\"\n\t\t\t\t\t>\n\t\n\t\t\t<span data-button-text >\n\t\t\tCookie-instellingen wijzigen\n\n\t\t\t\t\t<\/span>\n\t\n\t\t\t\t\t\n\t\t\n\t\n\t<\/button>\n\t\t\t\t\n\n\n\n\n\n\t\n\n<a\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer text-base font-bold py-3 border-2 border-red bg-red text-base-50 hocus:bg-red-700 hocus:border-red-700 px-6 font-body \"\n\t\t\thref=\"https&#x3A;&#x2F;&#x2F;www.youtube.com&#x2F;watch&#x3F;v&#x3D;BQUrBBSw46k\"\n\t\t\t\ttarget=\"_blank\" rel=\"noopener\"\n\t\t\t\t\t\t\t\t\t\t\t\t>\n\t\n\t\t\t<span data-button-text >\n\t\t\tZicht op Youtube.\n\n\t\t\t\t\t\t\t<span class=\"sr-only\">Opens in a new window<\/span>\n\t\t\t\t\t<\/span>\n\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"transition-transform group-hover:translate-x-2 group-focus-visible:translate-x-2  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M11.293 4.293a1 1 0 0 1 1.414 0l7 7a1 1 0 0 1 0 1.414l-7 7a1 1 0 0 1-1.414-1.414L16.586 13H5a1 1 0 1 1 0-2h11.586l-5.293-5.293a1 1 0 0 1 0-1.414Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n\n\t\t\t\n\t<\/a>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\t<template>\n\t\t\t\t\t<div data-component=\"oembed-video\" data-oembed=\"video\" class=\"cursor-pointer aspect-video\">\n\t\t\t<img decoding=\"async\" data-oembed=\"thumbnail\" class=\"absolute object-cover w-full h-full\" src=\"https:\/\/i.ytimg.com\/vi\/BQUrBBSw46k\/maxresdefault.jpg\" alt=\"\" loading=\"lazy\">\n\t\t<div class=\"w-full h-full iframe:absolute iframe:inset-0 iframe:w-full iframe:h-full\">\n\t\t<iframe loading=\"lazy\" title=\"Hoe publiek geld naar medicijnontwikkeling gaat.\" width=\"500\" height=\"281\" data-src=\"https:\/\/www.youtube.com\/embed\/BQUrBBSw46k?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n\t\t<div class=\"absolute transform -translate-x-1\/2 -translate-y-1\/2 top-1\/2 left-1\/2\">\n\t\t\t\n\n\n\n\n\n\t\n\t\n<button\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer rounded-full font-bold text-md aspect-square px-4 border-2 border-red bg-red text-base-50 hocus:bg-red-700 hocus:border-red-700 px-6 font-body btn--js-video-play\"\n\t\t\thref=\"https&#x3A;&#x2F;&#x2F;www.youtube.com&#x2F;watch&#x3F;v&#x3D;BQUrBBSw46k\"\n\t\t\t\t\t\t\t\t\t\taria-label=\"Video&#x20;afspelen\"\n\t\t\t\t\t\t>\n\t\n\t\n\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"m2 0 17 10L2 20z\"\/><\/svg><\/span>\n\n\t\t\t\n\t<\/button>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/template>\n<\/div>\n<\/p>\n<h3>Publiek geld in medicijnonderzoek en -ontwikkeling<\/h3>\n<p>Naast geld voor onderzoek aan publieke instellingen en universiteiten <button\n\tclass=\"inline-flex items-center gap-x-1 relative underline text-red decoration-dashed hocus:no-underline before:hidden before:w-0 before:h-0 before:absolute before:translate-x-1\/2 before:-top-[15px] before:left-1\/2 before:border-t-[13px] before:border-x-[13px] before:border-b-0 before:border-transparent before:border-t-beige\"\n\ttype=\"button\"\n\tdata-module=\"tooltip\"\n\tdata-tooltip-id=\"tooltip\"\n\tdata-title=\"(EUR 835 miljoen in 2017)\"\n\tdata-description=\" Bestaande uit EUR 780 miljoen Nederlandse financiering en EUR 55 miljoen Europees geld (zie ook rapport).\"\n\trole=\"tooltip\"\n>\n\t(EUR 835 miljoen in 2017)\n\t<span aria-hidden=\"true\" class=\"icon svg:w-[1em] svg:h-[1em]\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M11.941 7.52c-.341 0-.597-.096-.768-.288-.17-.192-.256-.437-.256-.736 0-.341.102-.624.304-.848.214-.224.502-.336.864-.336.363 0 .63.096.8.288.171.192.256.437.256.736 0 .363-.106.65-.32.864-.202.213-.49.32-.864.32h-.016Zm-.64 2.832-1.216-.288v-.848l2.48-.304h.032l.368.288v7.888l1.28.128V18h-4.24v-.784l1.296-.144v-6.72Z\" fill=\"currentColor\"\/><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M12 3.333a8.667 8.667 0 1 0 0 17.334 8.667 8.667 0 0 0 0-17.334ZM2 12C2 6.477 6.477 2 12 2s10 4.477 10 10-4.477 10-10 10S2 17.523 2 12Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n<\/button>\n, investeren nationale overheid en provincies fors in start-ups en spin-off biotechbedrijven, opgericht door onderzoekers die commercieel verder willen met kansrijke wetenschappelijke vindingen. Dit kapitaal wordt ge\u00efnvesteerd in een fase waarin het risico op een mislukking groot is. Pas als het medicijn kansrijk blijkt, volgen andere grote private investeerders die vervolgens hun aandelen voor het veelvoudige verkopen aan de farmaceutische industrie.<\/p>\n<blockquote><p>Ella Weggen (global health advocate bij Wemos): \u201cAls Nederlanders betalen we twee keer voor medicijnen: via de premies van onze zorgverzekering en via de belasting. En toch hebben we onvoldoende profijt van deze publieke investeringen. Bovendien worden sommige geneesmiddelen die met belastinggeld zijn ontwikkeld tegen exorbitant hoge prijzen verkocht, zoals het rapport laat zien. Dit ondermijnt gelijke toegang tot medicijnen en vormt een bedreiging voor ons recht op gezondheid.\u201d<\/p><\/blockquote>\n<p><a href=\"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Samenvatting-Overpriced-NL.pdf\">Lees de Nederlandse samenvatting<\/a><\/p>\n<h3>Transparantie en criteria voor investeringen ontbreken<\/h3>\n<p>De hoogte van de publieke bijdragen aan medicijnontwikkeling via investeringsfondsen is moeilijk te achterhalen omdat deze informatie niet openbaar is. Daarnaast worden er geen voorwaarden gesteld aan deze financiering, omdat dit volgens de betrokken investeerders een negatief effect zou hebben op hun return on investment.<\/p>\n<blockquote><p>Ella Weggen: \u201cEr is een groot spanningsveld tussen het belang om economische groei te bevorderen en het belang om medicijnen (en daarmee ook de zorg) betaalbaar te houden. De overheid zou een coherent beleid moeten voeren waarin publieke gezondheidsbelangen zwaar wegen. Daarnaast is transparantie over publieke investeringen nodig, en moeten voorwaarden gesteld worden aan publieke financiering in medicijnontwikkeling, zodat mensen daadwerkelijk profiteren van geneesmiddelen die met hun belastinggeld zijn ontwikkeld.\u201c<\/p><\/blockquote>\n<h3>Farma\u2019s other futures<\/h3>\n<p>Op 16 mei organiseren Wemos en Commons Network een <a href=\"https:\/\/rodehoed.nl\/programma\/farmas-other-futures\/\" target=\"_blank\" rel=\"noopener\">avond in de Rode Hoed<span class=\"sr-only\">(opens in new window)<\/span> <span class=\"icon inline-block ml-1 w-[0.875em]\"><svg width=\"24\" height=\"25\" viewBox=\"0 0 24 25\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M15.75 1.748a.75.75 0 0 1 .75-.75h6.75a.748.748 0 0 1 .524.213l.013.013c.132.135.213.32.213.524v6.75a.75.75 0 0 1-1.5 0v-4.94L8.78 17.279a.75.75 0 1 1-1.06-1.06l13.72-13.72H16.5a.75.75 0 0 1-.75-.75Z\" fill=\"currentColor\"\/><path d=\"M2.25 5.498A2.25 2.25 0 0 0 0 7.748v15a2.25 2.25 0 0 0 2.25 2.25h15a2.25 2.25 0 0 0 2.25-2.25v-9a.75.75 0 0 0-1.5 0v9a.75.75 0 0 1-.75.75h-15a.75.75 0 0 1-.75-.75v-15a.75.75 0 0 1 .75-.75h9a.75.75 0 0 0 0-1.5h-9Z\" fill=\"currentColor\"\/><\/svg>\n<\/span><\/a> met toekomstvisies die laten zien waarom betaalbare medicijnen w\u00e9l haalbaar zijn.\u00a0Met onder meer Lucien Hordijk (journalist), Robin Kok (CF patient), Carla Hollak (hoogleraar stofwisselingsziekten, UMC Amsterdam), Rob Henning (hoogleraar Farmacologie, Universiteit Groningen), Lilianne Ploumen (PvdA), Arnout Hoekstra (Lijsttrekker SP Europees Parlement) en Pia Dijkstra (D66).<\/p>\n\n\t\n\n\n\t<div  data-name=\"acf\/block-partners\" class=\"\">\n\t\t<div data-component=\"organisations\" class=\"p-4 bg-beige md:p-10\">\n\t<div class=\"flex flex-col gap-8\">\n\n\t\t\t\t\t<h3 class=\"text-xl font-bold sm:text-2xl font-heading heading-3\">Partners<\/h3>\n\t\t\n\t\t<ul class=\"grid justify-center grid-cols-1 gap-8 sm:grid-cols-2 md:gap-10 lg:gap-x-20 lg:gap-y-16\">\n\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\n<div data-component=\"teaser-organisation\" class=\"flex flex-col gap-2\">\n\t<h3 class=\"text-lg font-bold lg:text-xl font-heading\">Wemos <\/h3>\n\n\t<div class=\"text-base lg:text-md\">\n\t\t\n\t<\/div>\n\n\t\t\t<div>\n\t\t\t\n\n\n\n\n\n\n\t\n<a\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer transition-[padding] font-bold border-b-2 text-base sm:text-md pb-1 hocus:px-4  font-body \"\n\t\t\thref=\"https&#x3A;&#x2F;&#x2F;www.wemos.nl&#x2F;\"\n\t\t\t\ttarget=\"_blank\" rel=\"noopener\"\n\t\t\t\t\t\t\t\t\taria-label=\"Visit&#x20;website&#x3A;&#x20;Wemos\"\n\t\t\t\t\t\t>\n\t\n\t\t\t<span data-button-text class=\"break-all\">\n\t\t\tVisit website\n\n\t\t\t\t\t\t\t<span class=\"sr-only\">Opens in a new window<\/span>\n\t\t\t\t\t<\/span>\n\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"transition-transform group-hover:translate-x-2 group-focus-visible:translate-x-2  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M11.293 4.293a1 1 0 0 1 1.414 0l7 7a1 1 0 0 1 0 1.414l-7 7a1 1 0 0 1-1.414-1.414L16.586 13H5a1 1 0 1 1 0-2h11.586l-5.293-5.293a1 1 0 0 1 0-1.414Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n\n\t\t\t\n\t<\/a>\n\t\t<\/div>\n\t<\/div>\n\t\t\t\t<\/li>\n\t\t\t\t\t<\/ul>\n\n\t\t\t<\/div>\n<\/div>\n\t<\/div>\n\n\n\n\t\t\t\t\n\t<div  data-name=\"acf\/block-tag-cloud\" class=\"align\">\n\t\t<div class=\"flex flex-col gap-4\">\n\t\t\t\n\t\t\t<ul class=\"flex flex-wrap gap-2\">\n\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\n\n\t<a data-component=\"tag\" href=\"https:\/\/www.somo.nl\/nl\/ons-werk\/sectoren\/farmaceutische-industrie\/\" class=\"block px-3 py-1 font-bold rounded-full font-heading text-base-900 bg-beige text-xs md:text-sm hocus:underline\">\n\t\tFarmaceutische industrie\n\t<\/a>\n\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t<\/ul>\n\t\t<\/div>\n\t<\/div>\n\n\n\n<div  data-name=\"acf\/block-post-meta\" class=\"mt-6 alignwide alignwide--narrow\">\n\t<div class=\"flex flex-wrap items-center gap-4 lg:gap-7\">\n\n\t\t\t\t\t<div class=\"flex flex-wrap items-center gap-2\">\n\t\t\t\t\t\t\t\t\t<span class=\"sr-only\">Geplaatst in categorie:<\/span>\n\t\t\t\t\t<div data-component=\"badge\" class=\"flex\">\n\t\t<div class=\"relative px-2 py-1 text-sm antialiased font-bold lowercase font-heading text-base-50 bg-nightblue-700\">\n\t\tNieuws\n\t<\/div>\n<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t<div class=\"flex items-center gap-2\">\n\t\t\t<span class=\"sr-only\">Gepubliceerd op:<\/span>\n\t\t\t<span class=\"icon svg:w-[20px] svg:h-[20px]\" aria-hidden=\"true\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M6.75 0a.75.75 0 0 1 .75.75V3h9V.75a.75.75 0 0 1 1.5 0V3h3.75A2.25 2.25 0 0 1 24 5.25v16.5A2.25 2.25 0 0 1 21.75 24H2.25A2.25 2.25 0 0 1 0 21.75V5.25A2.25 2.25 0 0 1 2.25 3H6V.75A.75.75 0 0 1 6.75 0Zm9.75 4.5V6A.75.75 0 0 0 18 6V4.5h3.75a.75.75 0 0 1 .75.75V9h-21V5.25a.75.75 0 0 1 .75-.75H6V6a.75.75 0 0 0 1.5 0V4.5h9Zm6 6v11.25a.75.75 0 0 1-.75.75H2.25a.75.75 0 0 1-.75-.75V10.5h21Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n\t\t\t<time class=\"text-base\" datetime=\"2019-05-10\">10 mei 2019<\/time>\n\t\t<\/div>\n\n\t\t\n\t\t\t\t\t\t\t\t<div data-component=\"social-share\">\n\t<ul class=\"flex items-center\" data-module=\"social-share\">\n\t\t\t\t\t<li>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\n\t\n<button\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer font-bold text-base p-2  font-body hocus&#x3A;text-red&#x20;js--share\"\n\t\t\t\t\t\t\t\tdata-config=\"&#x7B;&quot;type&quot;&#x3A;&quot;linkedin&quot;,&quot;shareText&quot;&#x3A;null&#x7D;\"\n\t\t\t\t\taria-label=\"LinkedIn&#x20;-&#x20;Deze&#x20;knop&#x20;opent&#x20;een&#x20;deel-op-LinkedIn&#x20;dialoogvenster&#x20;in&#x20;een&#x20;nieuw&#x20;venster.\"\n\t\t\t\t\t\t>\n\t\n\t\n\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M4.544 6.21v12.905H.247V6.21h4.297Zm.274-3.983c.013 1.237-.925 2.226-2.422 2.226H2.37C.924 4.453 0 3.463 0 2.227 0 .964.964 0 2.422 0c1.471 0 2.383.964 2.396 2.227ZM20 11.719v7.396h-4.284v-6.901c0-1.732-.625-2.917-2.174-2.917-1.185 0-1.888.794-2.2 1.562-.105.287-.144.664-.144 1.055v7.2H6.914c.052-11.692 0-12.903 0-12.903h4.284v1.875h-.026c.56-.885 1.575-2.175 3.893-2.175 2.826 0 4.935 1.85 4.935 5.808Z\"\/><\/svg><\/span>\n\n\t\t\t\n\t<\/button>\n\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t<li>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\n\t\n<button\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer font-bold text-base p-2  font-body hocus&#x3A;text-red&#x20;js--share\"\n\t\t\t\t\t\t\t\tdata-config=\"&#x7B;&quot;type&quot;&#x3A;&quot;twitter&quot;,&quot;shareText&quot;&#x3A;null&#x7D;\"\n\t\t\t\t\taria-label=\"X&#x20;-&#x20;Deze&#x20;knop&#x20;opent&#x20;een&#x20;deel-op-X&#x20;dialoogvenster&#x20;in&#x20;een&#x20;nieuw&#x20;venster.\"\n\t\t\t\t\t\t>\n\t\n\t\n\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"m.059 0 9.266 13.237L0 24h2.099l8.163-9.423L16.858 24H24l-9.787-13.982L22.892 0h-2.099l-7.518 8.678L7.2 0H.06Zm3.086 1.652h3.28l14.488 20.696h-3.28L3.145 1.652Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n\n\t\t\t\n\t<\/button>\n\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t<li>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\n\t\n<button\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer font-bold text-base p-2  font-body hocus&#x3A;text-red&#x20;js--share\"\n\t\t\t\t\t\t\t\tdata-config=\"&#x7B;&quot;type&quot;&#x3A;&quot;facebook&quot;,&quot;shareText&quot;&#x3A;null&#x7D;\"\n\t\t\t\t\taria-label=\"Facebook&#x20;-&#x20;Deze&#x20;knop&#x20;opent&#x20;een&#x20;deel-op-Facebook&#x20;dialoogvenster&#x20;in&#x20;een&#x20;nieuw&#x20;venster.\"\n\t\t\t\t\t\t>\n\t\n\t\n\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M11.875 3.75H15V0h-3.125A4.38 4.38 0 0 0 7.5 4.375V6.25H5V10h2.5v10h3.75V10h3.125L15 6.25h-3.75V4.375c0-.339.286-.625.625-.625Z\"\/><\/svg><\/span>\n\n\t\t\t\n\t<\/button>\n\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t<li>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\n\t\n<button\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer font-bold text-base p-2  font-body hocus&#x3A;text-red&#x20;js--share\"\n\t\t\t\t\t\t\t\tdata-config=\"&#x7B;&quot;type&quot;&#x3A;&quot;whatsapp&quot;,&quot;shareText&quot;&#x3A;null&#x7D;\"\n\t\t\t\t\taria-label=\"Whatsapp&#x20;-&#x20;Deze&#x20;knop&#x20;opent&#x20;een&#x20;deel-op-Whatsapp&#x20;dialoogvenster&#x20;in&#x20;een&#x20;nieuw&#x20;venster.\"\n\t\t\t\t\t\t>\n\t\n\t\n\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M17.083 2.906A9.908 9.908 0 0 0 10.037 0C4.55 0 .082 4.445.082 9.91c0 1.746.46 3.453 1.331 4.953L0 20l5.28-1.379a9.994 9.994 0 0 0 4.757 1.207h.004c5.488 0 9.959-4.445 9.959-9.91a9.836 9.836 0 0 0-2.917-7.012Zm-7.042 15.25a8.302 8.302 0 0 1-4.216-1.148l-.302-.18-3.132.817.836-3.04-.197-.312A8.149 8.149 0 0 1 1.763 9.91c0-4.543 3.713-8.238 8.282-8.238 2.21 0 4.29.86 5.853 2.414a8.173 8.173 0 0 1 2.422 5.828c-.004 4.547-3.717 8.242-8.279 8.242Zm4.538-6.172c-.247-.125-1.472-.722-1.7-.804-.227-.082-.392-.125-.561.125-.165.246-.644.804-.789.972-.145.164-.29.188-.538.063-.247-.125-1.052-.387-2.002-1.23-.738-.657-1.24-1.47-1.385-1.715-.146-.247-.016-.383.11-.504.113-.11.247-.29.372-.434.126-.145.165-.246.248-.414.082-.164.043-.309-.02-.434s-.561-1.343-.765-1.84c-.2-.484-.409-.417-.562-.425-.145-.008-.31-.008-.475-.008a.922.922 0 0 0-.663.309c-.228.246-.872.847-.872 2.066 0 1.219.891 2.394 1.017 2.562.126.165 1.755 2.668 4.251 3.739.593.254 1.056.406 1.417.523.597.188 1.139.16 1.567.098.479-.07 1.472-.598 1.68-1.176.208-.578.208-1.074.145-1.176-.059-.11-.224-.172-.475-.297Z\"\/><\/svg><\/span>\n\n\t\t\t\n\t<\/button>\n\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t<li>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\n\t\n<a\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer font-bold text-base p-2  font-body hocus&#x3A;text-red&#x20;js--share\"\n\t\t\thref=\"javascript&#x3A;void&#x28;0&#x29;&#x3B;\"\n\t\t\t\ttarget=\"_blank\" rel=\"noopener\"\n\t\t\t\t\t\t\tdata-config=\"&#x7B;&quot;type&quot;&#x3A;&quot;email&quot;,&quot;shareText&quot;&#x3A;null&#x7D;\"\n\t\t\t\t\taria-label=\"E-mail&#x20;-&#x20;Dit&#x20;opent&#x20;je&#x20;e-mailclient\"\n\t\t\t\t\t\t>\n\t\n\t\n\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M20 7.067v8.862a1.79 1.79 0 0 1-1.786 1.785H1.786A1.791 1.791 0 0 1 0 15.93V7.067a6.21 6.21 0 0 0 1.127.97C2.98 9.3 4.855 10.56 6.674 11.889c.938.692 2.098 1.54 3.315 1.54h.022c1.217 0 2.377-.848 3.315-1.54 1.82-1.317 3.694-2.589 5.558-3.85A6.574 6.574 0 0 0 20 7.067Zm0-3.281c0 1.25-.926 2.377-1.908 3.058-1.742 1.205-3.494 2.41-5.224 3.627-.725.502-1.953 1.529-2.857 1.529H9.99c-.904 0-2.132-1.027-2.857-1.529C5.402 9.254 3.65 8.049 1.92 6.844 1.127 6.308 0 5.047 0 4.03 0 2.938.592 2 1.786 2h16.428C19.185 2 20 2.804 20 3.786Z\"\/><\/svg><\/span>\n\n\t\t\t\n\t<\/a>\n\t\t\t\t\t\t\t<\/li>\n\t\t\t<\/ul>\n<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n\t<div  data-name=\"acf\/block-posts\" class=\"py-8 bg-blue alignwide md:py-10 lg:py-16\">\n\t\t\n\t\t<div class=\"flex flex-col gap-4 md:gap-8\">\n\n\t\t\t\t\t\t\t<h2 class=\"text-xl font-bold font-heading md:text-2xl lg:text-3xl\">Related news<\/h2>\n\t\t\t\n\t\t\t\t\t\t<ul class=\"grid items-stretch grid-cols-1 gap-4 xl:gap-6 xl:grid-cols-3  \">\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t<li class=\" xl:min-h-[550px]\">\n\t\t\t\t\t\t\t\t\t\n\t\t\n\t\n\t\t<div data-component=\"teaser-opinion\" class=\"@container relative h-full transition-colors bg-beige\">\n\t<div class=\"flex flex-col gap-4 px-6 pt-10 pb-6\">\n\t\t<a href=\"https:\/\/www.somo.nl\/nl\/datahonger-wint-het-van-medisch-beroepsgeheim-in-europese-wet-voor-gezondheidsdata\/\" class=\"break-words font-bold font-heading absolute-link hocus:underline   text-xl md:text-2xl lg:text-3xl\">\n\t\t\tDatahonger wint het van medisch beroepsgeheim in Europese wet voor gezondheidsdata\n\t\t<\/a>\n\n\t\t\t\t\t<div class=\"absolute top-0 left-0 flex gap-2 flex-start\">\n\t\t\t\t<div>\n\t\t\t\t\t<span class=\"sr-only\">Geplaatst in categorie:<\/span>\n\t\t\t\t\t<div data-component=\"badge\" class=\"flex\">\n\t\t<div class=\"relative px-2 py-1 text-sm antialiased font-bold lowercase font-heading text-base-50 bg-nightblue-700\">\n\t\tOpinie\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"lg:hidden\">\n\t\t\t\t\t\t\n<div data-component=\"badge-author\" class=\"min-h-[29px] relative inline-flex items-stretch font-normal font-heading bg-blue text-base-900\">\n\t\t\t<div class=\"image:h-full aspect-square image:max-w-[29px] image:object-cover lg:image:max-w-[58px]\">\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"100\" height=\"100\" src=\"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-100x100.jpg?image-crop-positioner-ts=1711371692\" class=\"attachment-square-md size-square-md\" alt=\"\" srcset=\"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-100x100.jpg?image-crop-positioner-ts=1711371692 100w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-300x300.jpg?image-crop-positioner-ts=1711371692 300w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-1024x1024.jpg?image-crop-positioner-ts=1711371692 1024w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-150x150.jpg?image-crop-positioner-ts=1711371692 150w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-768x768.jpg?image-crop-positioner-ts=1711371692 768w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-1536x1536.jpg?image-crop-positioner-ts=1711371692 1536w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-50x50.jpg?image-crop-positioner-ts=1711371692 50w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR.jpg?image-crop-positioner-ts=1711371692 2048w\" sizes=\"auto, (max-width: 100px) 100vw, 100px\" \/>\n\t\t<\/div>\n\t\t<div class=\"self-center px-2 lg:px-4\">\n\t\t\n\t\t\t\t\t<span class=\"block text-sm break-words lg:text-lg\">\n\t\t\t\tIrene Schipper\n\t\t\t<\/span>\n\t\t\t<\/div>\n<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t<div class=\"hidden lg:block  \">\n\t\t\t\t\n<div data-component=\"badge-author\" class=\"min-h-[29px] relative inline-flex items-stretch font-normal font-heading bg-blue text-base-900\">\n\t\t\t<div class=\"image:h-full aspect-square image:max-w-[29px] image:object-cover lg:image:max-w-[58px]\">\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"100\" height=\"100\" src=\"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-100x100.jpg?image-crop-positioner-ts=1711371692\" class=\"attachment-square-md size-square-md\" alt=\"\" srcset=\"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-100x100.jpg?image-crop-positioner-ts=1711371692 100w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-300x300.jpg?image-crop-positioner-ts=1711371692 300w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-1024x1024.jpg?image-crop-positioner-ts=1711371692 1024w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-150x150.jpg?image-crop-positioner-ts=1711371692 150w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-768x768.jpg?image-crop-positioner-ts=1711371692 768w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-1536x1536.jpg?image-crop-positioner-ts=1711371692 1536w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR-50x50.jpg?image-crop-positioner-ts=1711371692 50w, https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2024\/03\/44A0380IreneS-SOMO@MarjoryHaringa-LR.jpg?image-crop-positioner-ts=1711371692 2048w\" sizes=\"auto, (max-width: 100px) 100vw, 100px\" \/>\n\t\t<\/div>\n\t\t<div class=\"self-center px-2 lg:px-4\">\n\t\t\n\t\t\t\t\t<span class=\"block text-sm break-words lg:text-lg\">\n\t\t\t\tIrene Schipper\n\t\t\t<\/span>\n\t\t\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t\n\t\t<span class=\"sr-only\">Gepubliceerd op:<\/span>\n\t\t<time class=\"text-sm md:text-base\" datetime=\"2024-04-18\">18 april 2024<\/time>\n\t<\/div>\n<\/div>\n\n\t\n\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t<li class=\" xl:min-h-[550px]\">\n\t\t\t\t\t\t\t\t\t\n\t\t\n\t\n\t\t<div data-component=\"teaser-statement\" class=\"@container relative h-full transition-colors bg-beige\">\n\t<div class=\"flex flex-col gap-4 px-6 pt-10 pb-6\">\n\t\t<a href=\"https:\/\/www.somo.nl\/nl\/coalitie-van-maatschappelijke-organisaties-roept-de-eu-op-om-de-belangen-van-patienten-en-burgers-centraal-te-stellen-in-de-european-health-data-space\/\" class=\"break-words italic font-body absolute-link hocus:underline   text-xl md:text-2xl lg:text-3xl\">\n\t\t\tMaatschappelijke organisaties roepen  de EU op om de belangen van pati\u00ebnten en burgers centraal te stellen in de European Health Data Space\n\t\t<\/a>\n\t\t\t\t\t<div class=\"absolute top-0 left-0\">\n\t\t\t\t<span class=\"sr-only\">Geplaatst in categorie:<\/span>\n\t\t\t\t<div data-component=\"badge\" class=\"flex\">\n\t\t<div class=\"relative px-2 py-1 text-sm antialiased font-bold lowercase font-heading text-base-50 bg-nightblue-700\">\n\t\tVerklaring\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t\n\t\t<span class=\"sr-only\">Gepubliceerd op:<\/span>\n\t\t<time class=\"text-sm md:text-base\" datetime=\"2024-02-28\">28 februari 2024<\/time>\n\t<\/div>\n<\/div>\n\n\t\n\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t<li class=\" xl:min-h-[550px]\">\n\t\t\t\t\t\t\t\t\t\n\t\t\n\t\n\t\t<div data-component=\"teaser-opinion\" class=\"@container relative h-full transition-colors bg-beige\">\n\t<div class=\"flex flex-col gap-4 px-6 pt-10 pb-6\">\n\t\t<a href=\"https:\/\/www.somo.nl\/nl\/bij-kankermedicijn-trodelvy-is-alles-gericht-op-de-aandeelhouders\/\" class=\"break-words font-bold font-heading absolute-link hocus:underline   text-xl md:text-2xl lg:text-3xl\">\n\t\t\tBij kankermedicijn Trodelvy is alles gericht op de aandeelhouders\n\t\t<\/a>\n\n\t\t\t\t\t<div class=\"absolute top-0 left-0 flex gap-2 flex-start\">\n\t\t\t\t<div>\n\t\t\t\t\t<span class=\"sr-only\">Geplaatst in categorie:<\/span>\n\t\t\t\t\t<div data-component=\"badge\" class=\"flex\">\n\t\t<div class=\"relative px-2 py-1 text-sm antialiased font-bold lowercase font-heading text-base-50 bg-nightblue-700\">\n\t\tOpinie\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\n\t\t<span class=\"sr-only\">Gepubliceerd op:<\/span>\n\t\t<time class=\"text-sm md:text-base\" datetime=\"2023-04-12\">12 april 2023<\/time>\n\t<\/div>\n<\/div>\n\n\t\n\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t<\/ul>\n\n\t\t\t\t\t\t\t<div class=\"flex justify-center\">\n\t\t\t\t\t\n\n\n\n\n\n\t\n\n<a\n\tclass=\"group inline-flex gap-2 items-center group cursor-pointer text-base font-bold py-3 border-2 border-base-900 bg-transparent text-base-900 hocus:border-red px-6 font-body \"\n\t\t\thref=\"https&#x3A;&#x2F;&#x2F;www.somo.nl&#x2F;nl&#x2F;laatste-nieuws&#x2F;\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t>\n\t\n\t\t\t<span data-button-text >\n\t\t\tLaatste updates\n\n\t\t\t\t\t<\/span>\n\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t<span class=\"transition-transform group-hover:translate-x-2 group-focus-visible:translate-x-2  flex items-center justify-center w-[1.5em] h-[1.5em] icon group-expanded:hidden\" aria-hidden=\"true\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M11.293 4.293a1 1 0 0 1 1.414 0l7 7a1 1 0 0 1 0 1.414l-7 7a1 1 0 0 1-1.414-1.414L16.586 13H5a1 1 0 1 1 0-2h11.586l-5.293-5.293a1 1 0 0 1 0-1.414Z\" fill=\"currentColor\"\/><\/svg>\n<\/span>\n\n\t\t\t\n\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t<\/div>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Onderzoek toont grote publieke investeringen in medicijnontwikkeling Vandaag publiceren SOMO en Wemos het rapport \u2018Overpriced\u2019 waaruit blijkt dat er zowel direct als indirect veel publiek geld in de ontwikkeling van nieuwe medicijnen wordt gestoken. Naast directe financiering van universiteiten, gaat&#8230;<\/p>\n","protected":false},"author":4,"featured_media":16175,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"editor_notices":[],"footnotes":""},"categories":[],"tags":[26],"somo_context":[],"somo_post_format":[2],"somo_sector":[5888],"somo_issue":[],"somo_company":[5167,5168,5169,167],"somo_country":[],"class_list":["post-16174","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-farmaceutische-industrie","somo_post_format-news","somo_sector-farmaceutische-industrie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dure medicijnen ontwikkeld met belastinggeld - SOMO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dure medicijnen ontwikkeld met belastinggeld - SOMO\" \/>\n<meta property=\"og:description\" content=\"Onderzoek toont grote publieke investeringen in medicijnontwikkeling Vandaag publiceren SOMO en Wemos het rapport \u2018Overpriced\u2019 waaruit blijkt dat er zowel direct als indirect veel publiek geld in de ontwikkeling van nieuwe medicijnen wordt gestoken. Naast directe financiering van universiteiten, gaat...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/\" \/>\n<meta property=\"og:site_name\" content=\"SOMO\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SOMOamsterdam\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-10T00:00:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-10T16:01:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2500\" \/>\n\t<meta property=\"og:image:height\" content=\"1569\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@somo\" \/>\n<meta name=\"twitter:site\" content=\"@somo\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Dure medicijnen ontwikkeld met belastinggeld\",\"datePublished\":\"2019-05-10T00:00:28+00:00\",\"dateModified\":\"2023-07-10T16:01:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/\"},\"wordCount\":563,\"publisher\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/05\\\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg\",\"keywords\":[\"Farmaceutische industrie\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/\",\"url\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/\",\"name\":\"Dure medicijnen ontwikkeld met belastinggeld - SOMO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/05\\\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg\",\"datePublished\":\"2019-05-10T00:00:28+00:00\",\"dateModified\":\"2023-07-10T16:01:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/05\\\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg\",\"contentUrl\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/05\\\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg\",\"width\":2500,\"height\":1569},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/dure-medicijnen-ontwikkeld-met-belastinggeld\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dure medicijnen ontwikkeld met belastinggeld\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/\",\"name\":\"SOMO\",\"description\":\"Stichting Onderzoek Multinationale Ondernemingen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#organization\",\"name\":\"SOMO\",\"url\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2023\\\/04\\\/SOMO-Logo-Rood.svg\",\"contentUrl\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2023\\\/04\\\/SOMO-Logo-Rood.svg\",\"width\":1,\"height\":1,\"caption\":\"SOMO\"},\"image\":{\"@id\":\"https:\\\/\\\/www.somo.nl\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/SOMOamsterdam\\\/\",\"https:\\\/\\\/x.com\\\/somo\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/somo\"]},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dure medicijnen ontwikkeld met belastinggeld - SOMO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/","og_locale":"nl_NL","og_type":"article","og_title":"Dure medicijnen ontwikkeld met belastinggeld - SOMO","og_description":"Onderzoek toont grote publieke investeringen in medicijnontwikkeling Vandaag publiceren SOMO en Wemos het rapport \u2018Overpriced\u2019 waaruit blijkt dat er zowel direct als indirect veel publiek geld in de ontwikkeling van nieuwe medicijnen wordt gestoken. Naast directe financiering van universiteiten, gaat...","og_url":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/","og_site_name":"SOMO","article_publisher":"https:\/\/www.facebook.com\/SOMOamsterdam\/","article_published_time":"2019-05-10T00:00:28+00:00","article_modified_time":"2023-07-10T16:01:13+00:00","og_image":[{"width":2500,"height":1569,"url":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@somo","twitter_site":"@somo","twitter_misc":{"Geschreven door":"","Geschatte leestijd":"3 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#article","isPartOf":{"@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/"},"author":{"name":"","@id":""},"headline":"Dure medicijnen ontwikkeld met belastinggeld","datePublished":"2019-05-10T00:00:28+00:00","dateModified":"2023-07-10T16:01:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/"},"wordCount":563,"publisher":{"@id":"https:\/\/www.somo.nl\/nl\/#organization"},"image":{"@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#primaryimage"},"thumbnailUrl":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg","keywords":["Farmaceutische industrie"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/","url":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/","name":"Dure medicijnen ontwikkeld met belastinggeld - SOMO","isPartOf":{"@id":"https:\/\/www.somo.nl\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#primaryimage"},"image":{"@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#primaryimage"},"thumbnailUrl":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg","datePublished":"2019-05-10T00:00:28+00:00","dateModified":"2023-07-10T16:01:13+00:00","breadcrumb":{"@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#primaryimage","url":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg","contentUrl":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2019\/05\/Clinic-Diagnosis-Daily-Report-Checklist-Doctor-3222079-CCO-credits-MaxPixel.freegreatpicture.com_.jpg","width":2500,"height":1569},{"@type":"BreadcrumbList","@id":"https:\/\/www.somo.nl\/nl\/dure-medicijnen-ontwikkeld-met-belastinggeld\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.somo.nl\/nl\/"},{"@type":"ListItem","position":2,"name":"Dure medicijnen ontwikkeld met belastinggeld"}]},{"@type":"WebSite","@id":"https:\/\/www.somo.nl\/nl\/#website","url":"https:\/\/www.somo.nl\/nl\/","name":"SOMO","description":"Stichting Onderzoek Multinationale Ondernemingen","publisher":{"@id":"https:\/\/www.somo.nl\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.somo.nl\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.somo.nl\/nl\/#organization","name":"SOMO","url":"https:\/\/www.somo.nl\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.somo.nl\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2023\/04\/SOMO-Logo-Rood.svg","contentUrl":"https:\/\/www.somo.nl\/nl\/wp-content\/uploads\/sites\/2\/2023\/04\/SOMO-Logo-Rood.svg","width":1,"height":1,"caption":"SOMO"},"image":{"@id":"https:\/\/www.somo.nl\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SOMOamsterdam\/","https:\/\/x.com\/somo","https:\/\/www.linkedin.com\/company\/somo"]},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/posts\/16174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/comments?post=16174"}],"version-history":[{"count":1,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/posts\/16174\/revisions"}],"predecessor-version":[{"id":26980,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/posts\/16174\/revisions\/26980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/media\/16175"}],"wp:attachment":[{"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/media?parent=16174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/categories?post=16174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/tags?post=16174"},{"taxonomy":"somo_context","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/somo_context?post=16174"},{"taxonomy":"somo_post_format","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/somo_post_format?post=16174"},{"taxonomy":"somo_sector","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/somo_sector?post=16174"},{"taxonomy":"somo_issue","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/somo_issue?post=16174"},{"taxonomy":"somo_company","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/somo_company?post=16174"},{"taxonomy":"somo_country","embeddable":true,"href":"https:\/\/www.somo.nl\/nl\/wp-json\/wp\/v2\/somo_country?post=16174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}